Worth reading
48Recurring
Scored from 4 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
913
unitsWording
Definitive
How definitive the wording is.Details of issuance or disposal
Issuance of stock compensation-type stock options (stock acquisition rights)
発行・処分する株式数
91,300 shares (913 share acquisition rights × 100 shares per right)
Intended allottee
Name The Company's directors (excluding outside directors and part-time directors) / Number of Employees 4 / Number of stock acquisition rights 528, Name The Company's executive officers with titles and senior executive officers (excluding those concurrently serving as directors and part-time executive officers) / Number of Employees 5 / Number of stock acquisition rights 385
The payment amount for the share acquisition rights will be calculated by multiplying the fair value per share calculated using the Black-Scholes model on the allotment date by the number of shares underlying the rights. The payment will be offset against compensation receivables instead of being made in cash.
Amount of funds to be raised
No funds will be raised because no cash payment is required.
Total Stock-Based Compensation
The payment amount for the share acquisition rights will be calculated based on the fair value calculated using the Black-Scholes model. The specific amount is Not disclosed.
Terms of the stock acquisition rights
Exercise price
¥1 per share. Amendment provisions are Not disclosed (stated as a fixed amount).
Exercise period
Start Date 16 July 2026 / End date 15 July 2066
Number of Stock Acquisition Rights
Total number issued 913 / Number of unexercised units Not disclosed
Reason for acquisition without consideration
If a holder of the share acquisition rights becomes unable to exercise the rights, or if a proposal for a merger, company split, share exchange, share transfer, conversion into a company with transfer restrictions, or similar transaction is approved.
Categories and Number of Persons Covered
Category The Company's directors (excluding outside directors and part-time directors) / Number of Employees 4 / Number of allocated stock acquisition rights 528, Category The Company's executive officers with titles and senior executive officers (excluding those concurrently serving as directors and part-time executive officers) / Number of Employees 5 / Number of allocated stock acquisition rights 385
Basis for determining the amount to be paid
The fair value per share of the stock options calculated using the Black-Scholes model on the allotment date. The periods used for the reference closing price and average share price, and the discount and premium rates, are Not disclosed.
Procedures under the Corporate Code of Conduct
Resolution of the Board of Directors. Whether an independent third-party opinion was obtained or shareholder approval was sought is Not disclosed.
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of stock compensation-type stock options (stock acquisition rights) |
| Number of shares to be issued or disposed of | 91,300 shares (913 share acquisition rights × 100 shares per right) |
| Issue price and disposal price | The payment amount for the share acquisition rights will be calculated by multiplying the fair value per share calculated using the Black-Scholes model on the allotment date by the number of shares underlying the rights. The payment will be offset against compensation receivables instead of being made in cash. |
| Amount of funds to be raised | No funds will be raised because no cash payment is required. |
| Intended allottee | Name The Company's directors (excluding outside directors and part-time directors) / Number of Employees 4 / Number of stock acquisition rights 528, Name The Company's executive officers with titles and senior executive officers (excluding those concurrently serving as directors and part-time executive officers) / Number of Employees 5 / Number of stock acquisition rights 385 |
| Basis for determining the amount to be paid | The fair value per share of the stock options calculated using the Black-Scholes model on the allotment date. The periods used for the reference closing price and average share price, and the discount and premium rates, are Not disclosed. |
| Exercise price | ¥1 per share. Amendment provisions are Not disclosed (stated as a fixed amount). |
| Exercise period | Start Date 16 July 2026 / End date 15 July 2066 |
| Number of Stock Acquisition Rights | Total number issued 913 / Number of unexercised units Not disclosed |
| Reason for acquisition without consideration | If a holder of the share acquisition rights becomes unable to exercise the rights, or if a proposal for a merger, company split, share exchange, share transfer, conversion into a company with transfer restrictions, or similar transaction is approved. |
| Categories and Number of Persons Covered | Category The Company's directors (excluding outside directors and part-time directors) / Number of Employees 4 / Number of allocated stock acquisition rights 528, Category The Company's executive officers with titles and senior executive officers (excluding those concurrently serving as directors and part-time executive officers) / Number of Employees 5 / Number of allocated stock acquisition rights 385 |
| Total Stock-Based Compensation | The payment amount for the share acquisition rights will be calculated based on the fair value calculated using the Black-Scholes model. The specific amount is Not disclosed. |
| Procedures under the Corporate Code of Conduct | Resolution of the Board of Directors. Whether an independent third-party opinion was obtained or shareholder approval was sought is Not disclosed. |
Items this document does not state (15)
Total issue valueEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateTotal number of issued sharesTransfer restriction periodConditions for lifting transfer restrictionsUnderwriter / lead underwriterOverallotmentStock Split RatioMost recent equity financingMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To share with shareholders the benefits and risks of share price fluctuations and strengthen incentives for sustained improvements in performance and corporate value.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.